Hainan Poly Pharm (300630.SZ): Busulfex injection granted temporary approval by the US FDA.

16:28 03/03/2024

PulicPharma (300630.SZ) announced that the company recently received a notification from the U.S. Food and Drug Administration (FDA)...

Hainan Poly Pharm (300630.SZ) announced that the company recently received temporary approval from the Food and Drug Administration (FDA) of the United States for the injection of Brivudine. The indication for this drug is the treatment of partial onset seizures in patients aged 1 month and older.

Expand investment channels. Yangtze Optical Fibre and Cable Joint Stock (601869.SH) subsidiary, Changfei Capital, and EverProX Technologies intend to participate in the third phase of the Shanghai Merger and Acquisition Fund.

Andon Health's US subsidiary, 4-IN-1 Check and 3-IN-1 Check products, have received pre-market notification from the US FDA.

Guangzhou Sie Consulting (300687.SZ): The intelligent scheduling software technology research and development project based on model simulation led by the company has received official approval for project establishment.

Andon Health's US subsidiary, 4-IN-1 Check and 3-IN-1 Check products, have received pre-market notification from the US FDA.